Close Menu

Scientific American offers an article on recent research from Ohio State University that may turn out to be a biomarker that could help physicians prescribe the best antipsychotic drug for a patient with a mental illness. The research team found SNPs and other variation in the gene that codes for a receptor for dopamine, which could help explain why patients have long shown very different reactions to antipsychotic drugs.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.